ErVimmune develops revolutionary immunotherapies targeting non-conventional tumor antigens abnormally expressed in cancer cells and shared across tumors and patients, with a focus on addressing unmet medical needs in cold tumors
ErVimmune develops revolutionary immunotherapies targeting non-conventional tumor antigens abnormally expressed in cancer cells and shared across tumors and patients, with a focus on addressing unmet medical needs in cold tumors.